Aghajanian appointed as NRG Oncology Gynecologic Cancer Committee Chair

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Carol Aghajanian, MD of Memorial Sloan Kettering Cancer Center, was named chair of NRG Oncology’s Gynecologic Cancer Committee.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.
Cornell University has come to an agreement with the Trump administration that will unfreeze the university’s more than $250 million in interrupted federal research funding and “protect Cornell’s students from violations of federal civil rights laws, including from discrimination based on race, sex, or national origin, and promote America’s hardworking farming and rural communities” following accusations of antisemitism and discrimination in admissions.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login